Olipriya Das retweetledi
Olipriya Das
170 posts

Olipriya Das
@oli_odas
Currently Science Communicator @RussoPartners, protein scientist by training, dog lover, cooking enthusiast!
Boston, New York City Katılım Kasım 2013
559 Takip Edilen113 Takipçiler
Olipriya Das retweetledi

Olipriya Das retweetledi

#OPC1 Patient Spotlight – In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate with his master’s degree from Duke University.
Hear his story: bit.ly/3FtVMfc
@CIRMnews $LCTX #SCI #Inspiration #StoriesOfHope #ReplaceAndRestore

English
Olipriya Das retweetledi

The #BioFL2022 Company of the Year award was presented to @CatalystForRare, a commercial-stage biotechnology company dedicated to making a meaningful difference in the lives of patients suffering from rare diseases. Congrats!


English
Olipriya Das retweetledi

Join our growing team of professionals who are dedicated to advancing science with the goal of creating a better future. Learn more about your next career move here: tonixpharma.com/careers
English
Olipriya Das retweetledi

#Spotlight - Nicole Schreiber, Sr. Director of Clinical Strategy has been an integral member of our team! Nicole’s extensive experience with driving #clinicaltrials and forming strategic partnerships to advance drug development has been invaluable for driving our success.

English

@deenashanker Loafers from Clarks! they look good and are comfortable for long hours.
English
Olipriya Das retweetledi

Our #CEO, Pete O’Heeron, spoke with @HBJ_Chris of the @HouBizJournal to discuss the #Houston area and our #innovative #fibroblast technology.
Read the full article here: bizjournals.com/houston/news/2…

English
Olipriya Das retweetledi

#Fibroblasts are the most common cell in the body, comprising the main cell type of connective tissue. Fibroblasts have been shown to be more effective and potent than #stemcells in the #regeneration of tissue and reduction in #inflammation.
Learn more: fibrobiologics.com/fibroblast-tec…

English

@ItachoGR @radajbcordero @erica_fiorini @DrDavidMelamed @caipcoelho @DocLBrown2 I still have nightmares from this!
English
Olipriya Das retweetledi

New ideas are transforming the #healthcare industry. In this #ClarivatePodcast, we speak with Talking Heads' Jerry Harrison, today a rockstar healthcare entrepreneur, about how innovation is bringing startling ideas to life. Episode drops Aug 23: clarivate.com/podcasts/ideas….
#I2I

English
Olipriya Das retweetledi

Some #radiotherapies targeting #PSMA can cause salivary gland and kidney toxicities. We are using a “Radioantibody”, a #mAb linked to a #radioisotope for precise #tumor-targeting to reduce off-target toxicities and increase the safety profile of our drug.
>convergentrx.com/technology/
English
Olipriya Das retweetledi

Our CEO @DrPhilKantoff recently spoke with @Ch_Hops of @PrecOncNews about the advantages of Convergent’s, #PSMA-directed #radioantibody, CONV0-1α, as a treatment for #prostatecancer.
Read the full article here: precisiononcologynews.com/cancer/converg…
English
Olipriya Das retweetledi

Convergent’s mission is to utilize antibodies, which have greater specificity and affinity than small ligands, and repurpose them into #radioantibodies to create effective #radiotherapeutics for #cancer. Learn more: convergentrx.com/technology/

English

@adamfeuerstein Are science communicators/PR folks welcome? :) I’m in Boston, would love to attend!
English

I'd like to buy you a beer. OK, STAT is actually buying, but...
If you're a Boston-based biotech or pharma person, please hang out with me at the first STAT Locals event on Aug. 11 in Cambridge.
NO talks, NO panels, just summer fun.
Sign up here: marketing.statnews.com/stat-locals-bo…
English

.@NespressoUSA disappointed that your Boston #prudential store do not have recycling bags with shipping labels for their customers. Do you expect folks to find a store to drop all used pods? Plus, your store professionals were #unhelpful #rude
English
Olipriya Das retweetledi

#ADDF cofounder @a_hfillit shares a fresh perspective on #Alzheimer's research with @statnews, which now looks beyond #Aduhelm to a broader drug pipeline guided by the biology of aging that targets a combination of age-related changes, creating renewed optimism in the field.
STAT@statnews
Opinion: Alzheimer's research is moving beyond amyloid, with a wider breadth of targets and ability to stand up clinical trials that track and determine the relationship between biomarkers and clinical outcomes. buff.ly/3tk8TsO
English
Olipriya Das retweetledi

Meet us at 2022 American Society of Clinical Oncology (#ASCO22) Annual Meeting to learn about our full-service capabilities and visit Self Care Catalysts, an #AliraHealth company, booth #2045 to learn about #HealthStorylines, our digital operating system. lnkd.in/eAiKEdE

English

#noninvasive #eyescan detects #Alzheimers
Hear about the @RetiSpec technology from CEO @Eliavshaked in this conversation with @HealthBizBlog
David E. Williams@HealthBizBlog
Listening to "Alzheimer's diagnosis via retinal scan. Interview with @RetiSpec CEO Eliav Shaked" at buzzsprout.com/1367974/106859…
English



